Skip to content

Earnings yield at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.5%+0.3pp
Stryker logo
StrykerSYK
2.7%+0.6pp
IAR
Integra LifeSciencesIART
-67.5%
Solventum logo
SolventumSOLV
12.6%+9.8pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-13%-3.9pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-10.8%+25.3pp

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

Based on trailing twelve months.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s earnings yield?
Sanara MedTech Inc. (SMTI) reported earnings yield of -21.3% in Q1 2026.
How has Sanara MedTech Inc.'s earnings yield changed year-over-year?
Sanara MedTech Inc.'s earnings yield decreased by 412.7% year-over-year, from -4.2% to -21.3%.
What is the long-term trend for Sanara MedTech Inc.'s earnings yield?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s earnings yield has grown at a 69.0% compound annual growth rate (CAGR), from -1.3% to -18%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.